Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02874313Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Change from baseline in of retinal microaneurysm or hard exudates at 12 months. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02874313.